Brief: Dermapharm Confirms Outlook For 2023 Overall
Aug 29 (Reuters) - DERMAPHARM HOLDING SE DMPG.DE :
* PUBLISHES H1 2023 FINANCIAL REPORT, CONFIRMS OUTLOOK FOR
2023
OVERALL
* BOARD OF MANAGEMENT CONFIRMS OUTLOOK FOR 2023 OVERALL
Source text for Eikon: ID:nEQ6hyj98a
Further company coverage: DMPG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Dermapharm Holding SE
See all newsBrief: Dermapharm Confirms 2026 Forecast
Corrected: Germany's Dermapharm prelim H1 revenue rises, maintains outlook
Brief: Dermapharm Holding - Confirms Full-Year Guidance For 2026
Brief: Dermapharm Spokesperson - Dermapharm Is Engaged In A Constructive Dialogue With The Regulator
Refile: BUZZ-Dermapharm Holding slips after BaFin's audit